Profile of:

Khalid Alnaqbi


• Dr. Khalid Alnaqbi is a Consultant Rheumatologist and Chief of Rheumatology at Tawam Hospital (UAE), and Physician Lead of Rheumatology Committee of SEHA Medical Council. • Adjunct Associate Professor, UAE University • Vice President of Emirates Medical Association • Graduated from the College of Medicine and Health Sciences, UAE University. • Completed post-graduate residency training at the University of Toronto in Internal Medicine, Rheumatology, and Spondyloarthritis Fellowship. • Holds multiple board certifications (American and Canadian Boards in Internal Medicine and Rheumatology, Clinician Investigator Board, Patient Safety and Quality Improvement Program). • Published in peer-reviewed journals and wrote a book chapter on (Diagnosis of Ankylosing Spondylitis). Dr. Alnaqbi is a journal reviewer in prestigious journals. • Launched Spondyloarthritis Program: received the American accreditation (CCPC) which is the first of accreditation outside the USA. • Fellow of the American College of Physicians (FACP), a Fellow of the American College of Rheumatology (FACR), and a Fellow of the Royal College of Physicians & Surgeons of Canada (FRCPC). • Member of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). • Speaker in numerous national and international meetings. • Active on social media: Twitter, Instagram, LinkedIn • Co-investigator at Al Ain hospital of a multi-center observational study on [Patients with axial spondyloaRthritis: Multi-cOuntry Registry OF (PROOF) clinical characteristics, including radiographic progression, and burden of disease over 5 years in real-life setting]: August 2015 – August 2020 • Alnaqbi KA, Al Araimi T, Al Emadi S, Al Rayyes H, Saleh K, Bashir K, and Baraliakos X. Challenges in referral, diagnosis and management of patients with axial spondyloarthritis [abstract]. J Rheum Dis 2021:28 (S1): 286

Full name: Khalid Alnaqbi

Current country: United Arab Emirates

Membership level: Full

Type of membership: Member

Number of publications: 23

Consensus Recommendations on the use of Biosimilars in the Treatment of Rheumatic Diseases in the Gulf Region (2024)
https://pubmed.ncbi.nlm.nih.gov/38402494/

Development of the Emirates Multi-Criteria Decision Analysis Tool for Orphan Drugs (2024)
https://www.cureus.com/articles/217298-development-of-the-emirates-multi-criteria-decision-analysis-tool-for-orphan-drugs#!/

A rare twist: COVID-19 infection masquerading as IgA vasculitis in a hemophilia a patient (2024)
https://pubmed.ncbi.nlm.nih.gov/38353792/

Comprehensive description of the prevalence, serological and clinical characteristics, and visceral involvement of systemic sclerosis (scleroderma) in a large cohort from the United Arab Emirates Systemic Sclerosis Registry (2023)
https://pubmed.ncbi.nlm.nih.gov/37287950/

Shaping the Future: The Transformative Path of the Arab Board of Rheumatology (2023)
https://pubmed.ncbi.nlm.nih.gov/37736239/

An international comparative analysis and roadmap to sustainable biosimilar markets (2023)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10484585/

Cardiac Arrhythmia and Heart Failure Shortly After Starting Romosozumab for Osteoporosis: A Case-Based Review. (2023)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10714059/

Estimation of Patient Knowledge and Medication Preference on Rheumatic and Musculoskeletal Disorders in the United Arab Emirates: A Single‑Center Study at Cleveland Clinic Abu Dhabi (2023)
https://journals.lww.com/aora/fulltext/2023/03030/estimation_of_patient_knowledge_and_medication.4.aspx

Paradoxical Psoriasis and Worsening Spondylitis Due to Secukinumab in a Patient With Ankylosing Spondylitis: A Case Report and Literature Review (2023)
https://pubmed.ncbi.nlm.nih.gov/38111814/

Telehealth in rheumatology: the 2021 Arab League of Rheumatology Best Practice Guidelines (2022)
https://pubmed.ncbi.nlm.nih.gov/34993578/

Telehealth in rheumatology: the 2021 Arab League of Rheumatology Best Practice Guidelines (2022)
https://pubmed.ncbi.nlm.nih.gov/34993578/

APLAR recommendations on the practice of telemedicine in rheumatology (2022)
https://pubmed.ncbi.nlm.nih.gov/35043576/

Consensus statements for evaluation and nonpharmacological Management of Psoriatic Arthritis in UAE (2022)
https://pubmed.ncbi.nlm.nih.gov/35678066/

Reactive hip arthritis and avascular necrosis post severe COVID-19 infection: Case report and review of the literature (2022)
https://emj.emg-health.com/wp-content/uploads/sites/2/2022/03/Reactive-Hip-Arthritis-and-Avascular-Necrosis-After-Severe-COVID-19-Infection-A-Case-Report-and-Comprehensive-Review-of-Literature.pdf

Consensus statements for pharmacological management, monitoring of therapies, and comorbidity management of psoriatic arthritis in the United Arab Emirates (2022)
https://pubmed.ncbi.nlm.nih.gov/35678066/

Advancing early identification of axial spondyloarthritis: An interobserver comparison of extended role practitioners and rheumatologists (2020)
https://pubmed.ncbi.nlm.nih.gov/31043543/

Recommendations for the management of rheumatoid arthritis in the EMR: an adolopment of the 2015 American College of Rheumatology guidelines (2018)
https://pubmed.ncbi.nlm.nih.gov/30097896/

Adaptation of the 2015 American College of Rheumatology treatment guideline for rheumatoid arthritis for the Eastern Mediterranean Region: an exemplar of the GRADE Adolopment (2017)
https://pubmed.ncbi.nlm.nih.gov/28934978/

Analysis of the effect of the oral contraceptive pill on clinical outcomes in women with ankylosing spondylitis (2014)
https://pubmed.ncbi.nlm.nih.gov/24931958/

Prevalence and correlates of low back pain in primary care: what are the contributing factors in a rapidly developing country (2014)
https://pubmed.ncbi.nlm.nih.gov/24967035/

Development, sensibility, and reliability of the Toronto Axial Spondyloarthritis Questionnaire in inflammatory bowel disease (2013)
https://pubmed.ncbi.nlm.nih.gov/23996291/

An epidemiologic analysis of low back pain in primary care: a hot humid country and global comparison (2013)
https://pubmed.ncbi.nlm.nih.gov/23799711/

Rituximab in woman with ankylosing spondylitis and etanercept-related demyelinating disease: a case report (2012)
https://pubmed.ncbi.nlm.nih.gov/22644089/